GlaxoSmithKline PLC Director/PDMR Shareholding (7598M)
18 October 2016 - 5:00PM
UK Regulatory
TIDMGSK
RNS Number : 7598M
GlaxoSmithKline PLC
17 October 2016
GlaxoSmithKline plc (the 'Company')
Transaction notification
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Dr M M Slaoui
=== ======================== ===============================================
b) Position/status Chairman, Global Vaccines
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 October 2016 on ADSs
held in the Company's 2009 Performance
Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$42.39 1414.687
--------- ----------
$42.39 1569.750
--------- ----------
$42.39 1797.585
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
4,782.022
$42.39
=== ======================== ===============================================
e) Date of the transaction 2016-10-13
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr N Hirons
=== ======================== ===============================================
b) Position/status SVP, Global Ethics & Compliance
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 October 2016 on ADSs
held in the Company's 2009 Performance
Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$42.39 85.247
--------- ----------
=== ======================== ===============================================
d) Aggregated information n/a (single transaction)
Aggregated volume
Price
=== ======================== ===============================================
e) Date of the transaction 2016-10-13
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr B McNamara
=== ======================== ===============================================
b) Position/status CEO, GSK Consumer Healthcare
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 October 2016 on ADSs
held in the Company's 2009 Performance
Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$42.39 42.422
--------- ----------
$42.39 71.440
--------- ----------
$42.39 211.994
--------- ----------
$42.39 357.084
--------- ----------
$42.39 551.108
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
1234.048
$42.39
=== ======================== ===============================================
e) Date of the transaction 2016-10-13
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Mr D E Troy
=== ======================== ===============================================
b) Position/status SVP & General Counsel
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 October 2016 on ADSs
held in the Company's 2009 Performance
Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$42.39 876.858
--------- ----------
$42.39 972.968
--------- ----------
$42.39 1128.822
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
2978.648
$42.39
=== ======================== ===============================================
e) Date of the transaction 2016-10-13
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
1. Details of PDMR/person closely associated with them
('PCA')
=== =========================================================================
a) Name Dr K Slaoui
=== ======================== ===============================================
b) Position/status PCA of Dr M M Slaoui (Chairman, Global
Vaccines)
=== ======================== ===============================================
c) Initial notification/ Initial notification
amendment
=== ======================== ===============================================
2. Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
=== =========================================================================
a) Name GlaxoSmithKline plc
=== ======================== ===============================================
b) LEI 5493000HZTVUYLO1D793
=== ======================== ===============================================
3. Details of the transaction(s): section to be repeated
for (i) each type of instrument; (ii) each type of transaction;
(iii) each date; and (iv) each place where transaction(s)
has been conducted
=== =========================================================================
a) Description of American Depositary Shares ('ADSs')
the financial ISIN: US37733W1053
instrument
=== ======================== ===============================================
b) Nature of the Increase in notional interest in ADSs following
transaction the re-investment of dividends paid to
shareholders on 13 October 2016 on ADSs
held in the Company's 2009 Performance
Share Plan.
=== ======================== ===============================================
c) Price(s) and Price(s) Volume(s)
volume(s) --------- ----------
$42.39 22.991
--------- ----------
$42.39 24.324
--------- ----------
$42.39 25.675
--------- ----------
=== ======================== ===============================================
d) Aggregated information
Aggregated volume
Price
72.99
$42.39
=== ======================== ===============================================
e) Date of the transaction 2016-10-13
=== ======================== ===============================================
f) Place of the n/a
transaction
=== ======================== ===============================================
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHDDLFFQBFZFBD
(END) Dow Jones Newswires
October 18, 2016 02:00 ET (06:00 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2024 to May 2024
Gsk (LSE:GSK)
Historical Stock Chart
From May 2023 to May 2024